ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO0427

Patient-Reported Outcomes by Dialysis Weaning Strategy in Dialysis-Requiring AKI

Session Information

Category: Acute Kidney Injury

  • 102 AKI: Clinical, Outcomes, and Trials

Authors

  • Kwong, Yuenting Diana, UCSF Health, San Francisco, California, United States
  • Hsu, Chi-yuan, UCSF Health, San Francisco, California, United States
  • Siew, Edward D., Vanderbilt University Medical Center, Nashville, Tennessee, United States
  • Tuot, Delphine S., Zuckerberg San Francisco General, San Francisco, California, United States
  • Vijayan, Anitha, Intermountain Health, Salt Lake City, Utah, United States
  • Matzumura Umemoto, Gonzalo, Washington University in St Louis, St. Louis, Missouri, United States
  • McCoy, Ian Ellis, UCSF Health, San Francisco, California, United States
  • Birkelo, Bethany, University of Minnesota Medical School, Minneapolis, Minnesota, United States
  • Lee, Benjamin J., Houston Methodist, Houston, Texas, United States
  • Zhuo, Hanjing, UCSF Health, San Francisco, California, United States
  • Miaskowski, Christine, UCSF Health, San Francisco, California, United States
  • Liu, Kathleen D., UCSF Health, San Francisco, California, United States
Background

While a conservative dialysis strategy may promote renal recovery, reduced dialysis may worsen quality of life (QOL) or increase symptom burden. Differences in patient reported outcomes (PROs) were evaluated between Liberation from Acute Dialysis (LIBERATE-D) trial (NCT04218370) participants with dialysis requiring acute kidney injury (AKI-D) who were randomized to dialysis performed only for specific indications (conservative arm) or thrice weekly dialysis until recovery by urine output or creatinine clearance criteria (standard arm).

Methods

At enrollment, study day 7, 14, 28, and 90, participants were asked to rate their QOL on a 1 (very poor) to 7 (excellent) scale and to complete the Dialysis Symptoms Index (DSI) survey. Generalized estimating equations were applied to evaluate the associations between the study intervention and PRO trajectories.

Results

Across 220 participants, survey completion declined from 58% at enrollment to 39% at day 90. Altered mental status (n=52) was the primary reason for surveys completed at enrollment. Among responders, QOL improved and symptom burden decreased over 90 days. No differences were found in the trajectories for QOL (Figure 1), total symptom burden (Figure 2), or specific symptom occurrence between dialysis strategies (p-interaction>0.05).

Conclusion

PROs improved over 90 days following AKI-D. No differences in PROs were found between dialysis strategies, suggesting that a conservative dialysis strategy may not decrease patients' QOL or increase symptom burden while optimizing for renal recovery.

Acknowledgment

We thank all patients and families who participated in the trial and the LIBERATE-D study coordinators who assisted with the collection of patient reported outcomes.

Figure 1

Figure 2

Funding

  • NIDDK Support